Drug maker Cytokinetics Inc. lost $11.6 million in the fourth quarter and $49.3 million for 2010.
The South San Francisco company (NASDAQ: CYTK) lost $12.5 million a year earlier in the fourth quarter. Revenue rose slightly to $1.1 million from $1 million in the same quarter of 2009.
Cytokinetics lost $49.3 million in 2010, compared with a profit of $24.5 million in 2009, when $74.4 million in license revenue swelled its coffers.
No comments:
Post a Comment